General Information of This Payload
Payload ID
PAY0FKBCN
Name
WO2024140449A1+ADC13+payload
Synonyms
WO2024140449A1+ADC13+payload
   Click to Show/Hide
Formula
C35H34N4O9
Isosmiles
CC[C@]1(O)C(C=C2C3=NC4=CC5=C(OCO5)C=C4C(CCN(C(OCC6=CC=C(N)C=C6)=O)[C@@H]7CCOC7)=C3CN82)=C(COC1=O)C8=O
InChI
InChI=1S/C35H34N4O9/c1-2-35(43)26-12-28-31-24(14-39(28)32(40)25(26)17-45-33(35)41)22(23-11-29-30(48-18-47-29)13-27(23)37-31)7-9-38(21-8-10-44-16-21)34(42)46-15-19-3-5-20(36)6-4-19/h3-6,11-13,21,43H,2,7-10,14-18,36H2,1H3/t21-,35+/m1/s1
InChIKey
TTZCPUGQZXDRNB-QGFSVNGOSA-N
Pharmaceutical Properties
Molecule Weight
654.676
Polar area
164.67
Complexity
1985.287604
xlogp Value
3.3607
Heavy Count
48
Rot Bonds
7
Hbond acc
12
Hbond Donor
2
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
wO2024140449A1 ADC13 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
5-50 nM
Method Description
A Cell line test on OE-33
In Vitro Model Barrett adenocarcinoma, Adenocarcinoma of the esophagus OE-33 cells CVCL_0471
wO2024140449A1 ADC16 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
5-50 nM
Method Description
A Cell line test on OE-33
In Vitro Model Barrett adenocarcinoma, Adenocarcinoma of the esophagus OE-33 cells CVCL_0471
wO2024140449A1 ADC14 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
50-500 nM
Method Description
A Cell line test on OE-33
In Vitro Model Barrett adenocarcinoma, Adenocarcinoma of the esophagus OE-33 cells CVCL_0471
References
Ref 1 Antibody-drug conjugates of N-oxacycloalkyl substituted camptothecin derivatives